Cerus Stock Price, News & Analysis (NASDAQ:CERS)

$4.19 0.07 (1.70 %)
(As of 01/22/2018 04:00 PM ET)
Previous Close$4.12
Today's Range$4.09 - $4.22
52-Week Range$1.93 - $4.70
Volume525,915 shs
Average Volume814,415 shs
Market Capitalization$477.45 million
P/E Ratio-7.10
Dividend YieldN/A
Beta1.93

About Cerus (NASDAQ:CERS)

Cerus logoCerus Corporation is a biomedical products company. The Company is engaged in developing and commercializing the INTERCEPT Blood System for blood safety. The Company operates through blood safety segment. The Company's INTERCEPT Blood System is based on its technology for controlling biological replication, and is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The Company's INTERCEPT Blood System is designed to target and inactivate blood-borne pathogens, such as viruses, including human immunodeficiency virus (HIV), West Nile, Severe acute respiratory syndrome (SARS), hepatitis B and C; bacteria and parasites, as well as harmful white blood cells, while preserving the therapeutic properties of platelet, plasma and red blood cell transfusion products. The Company's INTERCEPT Blood System is for use with blood components, including plasma, platelets, and red blood cells.

Receive CERS News and Ratings via Email

Sign-up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices & Implants
Sub-IndustryHealth Care Supplies
SectorHealthcare
SymbolNASDAQ:CERS
CUSIP15708510
Phone+1-925-2886000

Debt

Debt-to-Equity Ratio0.80%
Current Ratio3.71%
Quick Ratio3.11%

Price-To-Earnings

Trailing P/E Ratio-7.10169491525424
Forward P/E Ratio-7.35
P/E GrowthN/A

Sales & Book Value

Annual Sales$39.28 million
Price / Sales12.33
Cash FlowN/A
Price / CashN/A
Book Value$0.56 per share
Price / Book7.48

Profitability

Trailing EPS($0.59)
Net Income$-62,900,000.00
Net Margins-159.35%
Return on Equity-142.18%
Return on Assets-67.72%

Miscellaneous

Employees204
Outstanding Shares115,560,000

Cerus (NASDAQ:CERS) Frequently Asked Questions

What is Cerus' stock symbol?

Cerus trades on the NASDAQ under the ticker symbol "CERS."

How were Cerus' earnings last quarter?

Cerus Co. (NASDAQ:CERS) released its quarterly earnings data on Thursday, November, 2nd. The biotechnology company reported ($0.12) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.15) by $0.03. The biotechnology company earned $10.80 million during the quarter, compared to analyst estimates of $11.95 million. Cerus had a negative net margin of 159.35% and a negative return on equity of 142.18%. Cerus's quarterly revenue was up 5.9% compared to the same quarter last year. During the same quarter last year, the business earned ($0.14) earnings per share. View Cerus' Earnings History.

When will Cerus make its next earnings announcement?

Cerus is scheduled to release their next quarterly earnings announcement on Tuesday, March, 6th 2018. View Earnings Estimates for Cerus.

Where is Cerus' stock going? Where will Cerus' stock price be in 2018?

5 Wall Street analysts have issued 1 year price objectives for Cerus' stock. Their predictions range from $5.00 to $10.00. On average, they anticipate Cerus' stock price to reach $6.20 in the next twelve months. View Analyst Ratings for Cerus.

What are Wall Street analysts saying about Cerus stock?

Here are some recent quotes from research analysts about Cerus stock:

  • 1. Cantor Fitzgerald analysts commented, "CERS announced preliminary 4Q17 product revenue of $16.2MM, ahead of FactSet consensus ($13.8MM), and our estimate ($13.2MM). Shares are up 8% in early trading." (1/5/2018)
  • 2. According to Zacks Investment Research, "Cerus Corporation is developing medical products based on a platform technology that prevents nucleic acid replication. The company's initial application of this technology is the development of systems to inactivate viruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. " (1/3/2018)

Who are some of Cerus' key competitors?

Who are Cerus' key executives?

Cerus' management team includes the folowing people:

  • Daniel N. Swisher Jr., Independent Chairman of the Board (Age 54)
  • William M. Greenman, President, Chief Executive Officer, Director (Age 50)
  • Kevin Dennis Green, Chief Financial Officer, Vice President - Finance (Age 44)
  • Caspar Hogeboom, President, Cerus Europe and EEMEA (Age 56)
  • Laurence M. Corash M.D., Senior Vice President, Chief Medical and Chief Scientific Officer, Director (Age 71)
  • Carol M. Moore, Senior Vice President - Regulatory Affairs, Quality and Clinical (Age 65)
  • Richard J. Benjamin, Chief Medical Officer
  • Vivek K. Jayaraman, Chief Commercial Officer (Age 41)
  • Chrystal N. Menard, Chief Legal Officer and General Counsel (Age 44)
  • Timothy Bruce Anderson, Independent Director (Age 68)

Who owns Cerus stock?

Cerus' stock is owned by a variety of of retail and institutional investors. Top institutional investors include Schwab Charles Investment Management Inc. (0.43%) and Berson & Corrado Investment Advisors LLC (0.05%). Company insiders that own Cerus stock include Carol Moore, Kevin Dennis Green, Laurence M Corash, Richard J Benjamin and William Mariner Greenman. View Institutional Ownership Trends for Cerus.

Who sold Cerus stock? Who is selling Cerus stock?

Cerus' stock was sold by a variety of institutional investors in the last quarter, including Berson & Corrado Investment Advisors LLC. Company insiders that have sold Cerus company stock in the last year include Carol Moore, Kevin Dennis Green, Richard J Benjamin and William Mariner Greenman. View Insider Buying and Selling for Cerus.

Who bought Cerus stock? Who is buying Cerus stock?

Cerus' stock was acquired by a variety of institutional investors in the last quarter, including Schwab Charles Investment Management Inc.. View Insider Buying and Selling for Cerus.

How do I buy Cerus stock?

Shares of Cerus can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Cerus' stock price today?

One share of Cerus stock can currently be purchased for approximately $4.12.

How big of a company is Cerus?

Cerus has a market capitalization of $477.45 million and generates $39.28 million in revenue each year. The biotechnology company earns $-62,900,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. Cerus employs 204 workers across the globe.

How can I contact Cerus?

Cerus' mailing address is 2550 Stanwell Dr, CONCORD, CA 94520-4813, United States. The biotechnology company can be reached via phone at +1-925-2886000 or via email at [email protected]


MarketBeat Community Rating for Cerus (CERS)

Community Ranking:  3.7 out of 5 (star star star)
Outperform Votes:  296 (Vote Outperform)
Underperform Votes:  107 (Vote Underperform)
Total Votes:  403
MarketBeat's community ratings are surveys of what our community members think about Cerus and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Cerus (NASDAQ:CERS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.802.803.003.00
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $6.20$6.60$7.00$7.80
Price Target Upside: 61.46% upside80.82% upside131.79% upside231.91% upside

Cerus (NASDAQ:CERS) Consensus Price Target History

Price Target History for Cerus (NASDAQ:CERS)

Cerus (NASDAQ:CERS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
1/8/2018Cantor FitzgeraldSet Price TargetBuy$5.00LowView Rating Details
12/8/2017BTIG ResearchReiterated RatingNeutral -> NeutralLowView Rating Details
12/1/2017Robert W. BairdReiterated RatingBuy$5.00LowView Rating Details
10/5/2017CowenSet Price TargetBuy$6.00N/AView Rating Details
3/8/2017FBR & CoSet Price TargetBuy$10.00LowView Rating Details
2/6/2016StephensReiterated RatingBuyN/AView Rating Details
(Data available from 1/22/2016 forward)

Earnings

Cerus (NASDAQ:CERS) Earnings History and Estimates Chart

Earnings by Quarter for Cerus (NASDAQ:CERS)

Cerus (NASDAQ CERS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2018        
11/2/2017Q3 2017($0.15)($0.12)$11.95 million$10.80 millionViewN/AView Earnings Details
8/3/2017Q2 2017($0.16)($0.16)$9.14 million$9.53 millionViewListenView Earnings Details
5/4/2017Q1 2017($0.17)($0.18)$8.98 million$7.01 millionViewListenView Earnings Details
3/7/2017Q4 2016($0.16)($0.13)$11.29 million$10.10 millionViewListenView Earnings Details
11/3/2016Q316($0.17)($0.14)$10.34 million$10.20 millionViewN/AView Earnings Details
8/4/2016Q216($0.17)($0.18)$8.88 million$9.25 millionViewN/AView Earnings Details
5/3/2016Q1($0.16)($0.17)$8.29 million$7.60 millionViewN/AView Earnings Details
3/8/2016Q415($0.16)($0.15)$9.72 million$9.70 millionViewListenView Earnings Details
11/5/2015Q315($0.16)($0.17)$10.00 million$8.04 millionViewN/AView Earnings Details
8/6/2015Q215($0.15)($0.17)$8.71 million$8.83 millionViewN/AView Earnings Details
5/5/2015Q214($0.16)($0.21)$7.70 million$7.70 millionViewN/AView Earnings Details
2/26/2015Q114($0.15)($0.25)$10.36 million$9.70 millionViewN/AView Earnings Details
11/4/2014Q413($0.13)($0.15)$9.83 million$10.36 millionViewN/AView Earnings Details
7/31/2014Q313($0.13)($0.16)$8.17 million$8.60 millionViewN/AView Earnings Details
5/1/2014Q313($0.09)($0.04)$9.65 million$7.86 millionViewN/AView Earnings Details
2/25/2014Q213($0.09)($0.10)$11.77 million$9.23 millionViewN/AView Earnings Details
10/29/2013($0.09)($0.29)$10.34 million$10.54 millionViewN/AView Earnings Details
7/30/2013Q2 2013($0.09)($0.10)ViewN/AView Earnings Details
4/30/2013Q1 2013($0.08)($0.11)ViewN/AView Earnings Details
2/28/2013Q4 2012($0.08)($0.11)ViewN/AView Earnings Details
11/7/2012Q3 2012($0.08)($0.10)ViewN/AView Earnings Details
8/2/2012Q2 2012($0.08)($0.17)ViewN/AView Earnings Details
5/1/2012Q1 2012($0.08)($0.08)ViewN/AView Earnings Details
2/28/2012Q4 2011($0.08)($0.09)ViewN/AView Earnings Details
11/1/2011Q3 2011($0.10)($0.06)ViewN/AView Earnings Details
7/28/2011Q2 2011($0.10)($0.13)ViewN/AView Earnings Details
4/28/2011Q1 2011($0.09)($0.11)ViewN/AView Earnings Details
3/3/2011Q4 2010($0.07)($0.05)ViewN/AView Earnings Details
10/28/2010Q3 2010($0.09)($0.10)ViewN/AView Earnings Details
7/29/2010Q2 2010($0.11)($0.14)ViewN/AView Earnings Details
4/29/2010Q1 2010($0.10)($0.13)ViewN/AView Earnings Details
2/23/2010Q4 2009($0.12)($0.13)ViewN/AView Earnings Details
10/29/2009Q3 2009($0.12)($0.16)ViewN/AView Earnings Details
7/30/2009Q2 2009($0.16)($0.19)ViewN/AView Earnings Details
4/30/2009Q1 2009($0.18)($0.21)ViewN/AView Earnings Details
2/26/2009Q4 2008($0.24)($0.20)ViewN/AView Earnings Details
10/30/2008Q3 2008($0.27)($0.27)ViewN/AView Earnings Details
7/31/2008Q2 2008($0.26)($0.28)ViewN/AView Earnings Details
5/1/2008Q1 2008($0.26)($0.16)ViewN/AView Earnings Details
2/21/2008Q4 2007($0.25)($0.32)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Cerus (NASDAQ:CERS) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.57 EPS
Next Year EPS Consensus Estimate: $-0.43 EPS

Dividends

Dividend History for Cerus (NASDAQ:CERS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Cerus (NASDAQ CERS) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 7.40%
Institutional Ownership Percentage: 55.70%
Insider Trades by Quarter for Cerus (NASDAQ:CERS)
Institutional Ownership by Quarter for Cerus (NASDAQ:CERS)

Cerus (NASDAQ CERS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/11/2017Laurence M CorashInsiderBuy92,796$2.45$227,350.201,375,711View SEC Filing  
3/15/2017Kevin Dennis GreenCFOSell2,343$4.21$9,864.03View SEC Filing  
3/15/2017William Mariner GreenmanInsiderSell8,786$4.21$36,989.06View SEC Filing  
3/14/2017Carol MooreSVPSell2,377$4.15$9,864.55View SEC Filing  
3/14/2017Richard J BenjaminInsiderSell1,189$4.15$4,934.353,000View SEC Filing  
8/22/2016Kevin Dennis GreenCFOSell17,150$6.80$116,620.00View SEC Filing  
8/19/2015Laurence M CorashInsiderBuy25,900$4.99$129,241.001,270,256View SEC Filing  
8/18/2015Laurence M CorashInsiderBuy84,600$4.77$403,542.00View SEC Filing  
11/10/2014William Mariner GreenmanCEOBuy21,800$3.93$85,674.00View SEC Filing  
11/19/2012William Mariner GreenmanCEOBuy3,200$3.02$9,664.00View SEC Filing  
11/16/2012Laurence M CorashInsiderBuy2,000$2.85$5,700.00View SEC Filing  
11/16/2012William Mariner GreenmanCEOBuy13,800$2.85$39,330.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Cerus (NASDAQ CERS) News Headlines

Source:
DateHeadline
Cerus Co. (CERS) Given Average Rating of "Hold" by BrokeragesCerus Co. (CERS) Given Average Rating of "Hold" by Brokerages
www.americanbankingnews.com - January 19 at 9:58 AM
Cantor Fitzgerald Weighs in on Cerus Co.s FY2017 Earnings (CERS)Cantor Fitzgerald Weighs in on Cerus Co.'s FY2017 Earnings (CERS)
www.americanbankingnews.com - January 10 at 6:56 AM
Cerus (CERS) Announces Prelim. Product Revenue Results for Q4Cerus (CERS) Announces Prelim. Product Revenue Results for Q4
www.streetinsider.com - January 8 at 5:28 PM
Cerus (CERS) Given a $5.00 Price Target by Cantor Fitzgerald AnalystsCerus (CERS) Given a $5.00 Price Target by Cantor Fitzgerald Analysts
www.americanbankingnews.com - January 8 at 11:18 AM
Cerus Corporation Announces Preliminary Product Revenue Results for Fourth Quarter and Full Year 2017Cerus Corporation Announces Preliminary Product Revenue Results for Fourth Quarter and Full Year 2017
finance.yahoo.com - January 8 at 9:48 AM
Cerus (CERS) Stock Rating Reaffirmed by Cantor FitzgeraldCerus (CERS) Stock Rating Reaffirmed by Cantor Fitzgerald
www.americanbankingnews.com - January 6 at 11:50 PM
Cerus (CERS) Lifted to Sell at BidaskClubCerus (CERS) Lifted to Sell at BidaskClub
www.americanbankingnews.com - January 6 at 12:30 PM
Cerus (CERS) Upgraded at ValuEngineCerus (CERS) Upgraded at ValuEngine
www.americanbankingnews.com - January 4 at 10:32 PM
Cerus (CERS) Downgraded by Zacks Investment ResearchCerus (CERS) Downgraded by Zacks Investment Research
www.americanbankingnews.com - January 3 at 10:46 PM
Should You Buy Cerus Corporation (NASDAQ:CERS) At $3.56?Should You Buy Cerus Corporation (NASDAQ:CERS) At $3.56?
finance.yahoo.com - January 3 at 5:26 PM
BidaskClub Lowers Cerus (CERS) to Strong SellBidaskClub Lowers Cerus (CERS) to Strong Sell
www.americanbankingnews.com - December 29 at 11:56 AM
Cerus Corp. :CERS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017Cerus Corp. :CERS-US: Earnings Analysis: Q3, 2017 By the Numbers : December 26, 2017
finance.yahoo.com - December 28 at 3:51 PM
Cerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : December 28, 2017Cerus Corp. breached its 50 day moving average in a Bearish Manner : CERS-US : December 28, 2017
finance.yahoo.com - December 28 at 3:51 PM
ETFs with exposure to Cerus Corp. : December 27, 2017ETFs with exposure to Cerus Corp. : December 27, 2017
finance.yahoo.com - December 28 at 3:51 PM
Cerus Co. (CERS) Given Consensus Rating of "Hold" by BrokeragesCerus Co. (CERS) Given Consensus Rating of "Hold" by Brokerages
www.americanbankingnews.com - December 25 at 10:04 AM
Should You Invest In The Oil & Gas Stock Cerus Energy Group Ltd (CVE:CEA)?Should You Invest In The Oil & Gas Stock Cerus Energy Group Ltd (CVE:CEA)?
finance.yahoo.com - December 19 at 5:22 PM
Cerus (CERS) Stock Rating Lowered by BidaskClubCerus (CERS) Stock Rating Lowered by BidaskClub
www.americanbankingnews.com - December 17 at 5:58 PM
Does Cerus Energy Group Ltd’s (CVE:CEA) Recent Track Record Look Strong?Does Cerus Energy Group Ltd’s (CVE:CEA) Recent Track Record Look Strong?
finance.yahoo.com - December 12 at 5:49 PM
Cerus (CERS) vs. Its Rivals Critical AnalysisCerus (CERS) vs. Its Rivals Critical Analysis
www.americanbankingnews.com - December 9 at 11:42 PM
Cerus (CERS) "Neutral" Rating Reaffirmed at BTIG ResearchCerus' (CERS) "Neutral" Rating Reaffirmed at BTIG Research
www.americanbankingnews.com - December 8 at 6:08 PM
Head-To-Head Review: Cerus (CERS) versus The CompetitionHead-To-Head Review: Cerus (CERS) versus The Competition
www.americanbankingnews.com - December 7 at 9:38 PM
Cerus (CERS) versus Its Competitors Financial AnalysisCerus (CERS) versus Its Competitors Financial Analysis
www.americanbankingnews.com - December 6 at 7:25 PM
Contrasting Cerus (CERS) & Its PeersContrasting Cerus (CERS) & Its Peers
www.americanbankingnews.com - December 6 at 7:24 PM
Head-To-Head Analysis: Cerus (CERS) versus Its RivalsHead-To-Head Analysis: Cerus (CERS) versus Its Rivals
www.americanbankingnews.com - December 5 at 9:26 PM
Cerus (CERS) vs. Its Competitors Critical ComparisonCerus (CERS) vs. Its Competitors Critical Comparison
www.americanbankingnews.com - December 4 at 8:44 AM
Contrasting Cerus (CERS) and Its RivalsContrasting Cerus (CERS) and Its Rivals
www.americanbankingnews.com - December 4 at 1:34 AM
Cerus (CERS) Given Buy Rating at Robert W. BairdCerus (CERS) Given Buy Rating at Robert W. Baird
www.americanbankingnews.com - December 1 at 8:38 PM
Comparing Cerus (CERS) and Its CompetitorsComparing Cerus (CERS) and Its Competitors
www.americanbankingnews.com - December 1 at 7:30 PM
Reviewing Cerus (CERS) & Its CompetitorsReviewing Cerus (CERS) & Its Competitors
www.americanbankingnews.com - December 1 at 11:16 AM
Cerus Corporation (CERS) Receives Average Recommendation of "Hold" from AnalystsCerus Corporation (CERS) Receives Average Recommendation of "Hold" from Analysts
www.americanbankingnews.com - November 30 at 9:56 AM
Head to Head Review: Cerus (CERS) and Its RivalsHead to Head Review: Cerus (CERS) and Its Rivals
www.americanbankingnews.com - November 30 at 9:02 AM
Head to Head Contrast: Cerus (CERS) vs. Its CompetitorsHead to Head Contrast: Cerus (CERS) vs. Its Competitors
www.americanbankingnews.com - November 27 at 3:56 PM
Critical Comparison: Cerus Corporation (CERS) & Its RivalsCritical Comparison: Cerus Corporation (CERS) & Its Rivals
www.americanbankingnews.com - November 25 at 9:26 AM
Head-To-Head Comparison: Cerus Corporation (CERS) vs. Its CompetitorsHead-To-Head Comparison: Cerus Corporation (CERS) vs. Its Competitors
www.americanbankingnews.com - November 25 at 3:26 AM
Factors of Influence in 2018, Key Indicators and Opportunity within REV Group, CoreLogic, M/I HomesFactors of Influence in 2018, Key Indicators and Opportunity within REV Group, CoreLogic, M/I Homes
www.nasdaq.com - November 22 at 5:48 PM
Factors of Influence in 2018, Key Indicators and Opportunity within REV Group, CoreLogic, M/I Homes, Halyard Health, Deckers Outdoor, and Cerus — New Research Emphasizes Economic GrowthFactors of Influence in 2018, Key Indicators and Opportunity within REV Group, CoreLogic, M/I Homes, Halyard Health, Deckers Outdoor, and Cerus — New Research Emphasizes Economic Growth
finance.yahoo.com - November 22 at 5:48 PM
Contrasting Cerus Corporation (CERS) and The CompetitionContrasting Cerus Corporation (CERS) and The Competition
www.americanbankingnews.com - November 22 at 11:31 AM
Analyzing Cerus (CERS) and Its RivalsAnalyzing Cerus (CERS) and Its Rivals
www.americanbankingnews.com - November 20 at 3:20 PM
Who Are The Largest Shareholders In Cerus Energy Group Ltd (TSXV:CEA)?Who Are The Largest Shareholders In Cerus Energy Group Ltd (TSXV:CEA)?
finance.yahoo.com - November 17 at 4:27 PM
Zacks.com highlights: Drive Shack, Cerus, ReWalk Robotics, Aerohive Networks and Cloud Peak EnergyZacks.com highlights: Drive Shack, Cerus, ReWalk Robotics, Aerohive Networks and Cloud Peak Energy
finance.yahoo.com - November 16 at 12:36 PM
Financial Survey: Cerus Corporation (CERS) vs. The CompetitionFinancial Survey: Cerus Corporation (CERS) vs. The Competition
www.americanbankingnews.com - November 15 at 3:30 PM
5 Breakout Stocks Offering Admirable Returns5 Breakout Stocks Offering Admirable Returns
finance.yahoo.com - November 14 at 5:35 PM
Cerus Corporation (CERS) vs. Its Peers Critical ReviewCerus Corporation (CERS) vs. Its Peers Critical Review
www.americanbankingnews.com - November 11 at 1:28 AM
Cerus Corporation (CERS) and Its Peers Critical ReviewCerus Corporation (CERS) and Its Peers Critical Review
www.americanbankingnews.com - November 10 at 5:22 AM
Cerus Corporation (CERS) Upgraded by Zacks Investment Research to BuyCerus Corporation (CERS) Upgraded by Zacks Investment Research to Buy
www.americanbankingnews.com - November 8 at 9:10 PM
Cerus (CERS) Receives IDE Approval to Initiate Phase III ReCePI StudyCerus (CERS) Receives IDE Approval to Initiate Phase III ReCePI Study
www.streetinsider.com - November 8 at 1:08 AM
Cerus Corporation Receives IDE Approval to Initiate Phase III ReCePI StudyCerus Corporation Receives IDE Approval to Initiate Phase III ReCePI Study
finance.yahoo.com - November 8 at 1:08 AM
Cerus (CERS) Receives IDE Approval to Initiate Phase III ReCePI Study - StreetInsider.comCerus (CERS) Receives IDE Approval to Initiate Phase III ReCePI Study - StreetInsider.com
www.streetinsider.com - November 7 at 8:06 PM
Cerus Corporation (CERS) Receives Consensus Rating of "Hold" from BrokeragesCerus Corporation (CERS) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - November 5 at 11:58 AM
Edited Transcript of CERS earnings conference call or presentation 2-Nov-17 8:15pm GMTEdited Transcript of CERS earnings conference call or presentation 2-Nov-17 8:15pm GMT
finance.yahoo.com - November 3 at 5:48 PM

SEC Filings

Cerus (NASDAQ:CERS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Cerus (NASDAQ:CERS) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Cerus (NASDAQ CERS) Stock Chart for Monday, January, 22, 2018

Loading chart…

This page was last updated on 1/22/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.